Ahmed et al. reported sensitivity and specificity of 90% and 88% respectively for men with prostate cancer and PSA < 20 ng/mL using USWE in comparison to 93% and 93% for those with PSA > 20 ng/mL [51]. The gene discussed is KLK3; the disease is prostate carcinoma.